Pharmacy Times July 25, 2024
Despite the century-long period of virus evolution, 6 of the 11 primates that received a cytomegalovirus-expressed flu vaccine survived the exposure to H5N1 flu.
A study published in Nature Communications shows a promising approach to developing a universal influenza vaccine with the intention of conferring lifetime immunity against an evolving virus after a single dose. According to the investigators, the “one and done” vaccine platform was tested against the virus that is believed to be the most likely to trigger the next pandemic.1
“Should a deadly virus such as H5N1 infect a human and ignite a pandemic, we need to quickly validate and deploy a new vaccine,” said co-corresponding author Douglas Reed, PhD, associate professor of immunology at the University...
Today's Sponsors
Today's Sponsor